Women, Food And Drug Administration | featured news

FDA questions studies of breast implant safety

FDA questions studies of breast implant safety

A U.S. Food and Drug Administration advisory panel began a two-day meeting Tuesday on silicone breast implants to consider ways to improve the effectiveness of post-approval safety studies.

 

FDA to hear appeal on breast cancer drug Avastin

The best-selling cancer drug in the world comes under federal scrutiny as drugmaker Roche makes a last-ditch effort to keep Avastin approved ...

 

‘Female Viagra' rejected by FDA panel

‘Female Viagra' rejected by FDA panel

A panel of health experts on Friday rejected the latest offering submitted for federal approval to treat lack of female libido: an antidepressant drug that failed to increase sexual desire in two studies.

 

FDA questions how well 'female Viagra' works

FDA questions how well 'female Viagra' works

The first pill designed to boost the female sex drive failed to make a significant impact on libido in two studies, federal health regulators said, though some women did report slightly more sexually satisfying experiences.

 

Subscribe to this RSS topic: Syndicate content